Literature DB >> 27676088

Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.

Gábor Raffai1, Julian H Lombard.   

Abstract

This study investigated the acute effects of angiotensin-(1-7) and AVE0991 on active tone and vasodilator responses to bradykinin and acetylcholine in isolated mesenteric arteries from Sprague-Dawley rats fed a high-salt (HS; 4% NaCl) versus a normal salt (NS; 0.4% NaCl) diet. Angiotensin-(1-7) and AVE0991 elicited relaxation, and angiotensin-(1-7) unmasked vasodilator responses to bradykinin in arteries from HS-fed rats. These effects of angiotensin-(1-7) and AVE0991 were inhibited by endothelium removal, A779, PD123319, HOE140 and L-NAME. Angiotensin-(1-7) also restored the acetylcholine-induced relaxation that was suppressed by the HS diet. Vasodilator responses to bradykinin and acetylcholine in the presence of angiotensin-(1-7) were mimicked by captopril and the AT2 receptor agonist CGP42112 in arteries from HS-fed rats. Thus, in contrast to salt-induced impairment of vascular relaxation in response to vasodilator stimuli, angiotensin-(1-7) induces endothelium-dependent and NO-mediated relaxation, unmasks bradykinin responses via activation of mas and AT2 receptors, and restores acetylcholine-induced vasodilation in HS-fed rats. AT2 receptor activation and angiotensin-converting enzyme (ACE) inhibition shared the ability of angiotensin-(1-7) to enhance bradykinin and acetylcholine responses in HS-fed rats. These findings suggest a therapeutic potential for mas and/or AT2 receptor activation and ACE inhibition in restoring endothelial function impaired by elevated dietary salt intake or other pathological conditions.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27676088      PMCID: PMC5079160          DOI: 10.1159/000448714

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  60 in total

1.  Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.

Authors:  M A Oliveira; Z B Fortes; R A Santos; M C Kosla; M H De Carvalho
Journal:  Peptides       Date:  1999       Impact factor: 3.750

Review 2.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

Review 3.  Why are converting enzyme inhibitors vasodilators?

Authors:  P M Vanhoutte; W Auch-Schwelk; M L Biondi; R R Lorenz; V B Schini; M J Vidal
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

4.  Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

Authors:  Pia E Walters; Tracey A Gaspari; Robert E Widdop
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

5.  Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles.

Authors:  Jessica R C Priestley; Matthew W Buelow; Scott T McEwen; Brian D Weinberg; Melanie Delaney; Sarah F Balus; Carlyn Hoeppner; Lynn Dondlinger; Julian H Lombard
Journal:  Microvasc Res       Date:  2013-04-27       Impact factor: 3.514

6.  Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta.

Authors:  Jiaxuan Zhu; Ines Drenjancevic-Peric; Scott McEwen; Jill Friesema; Danielle Schulta; Ming Yu; Richard J Roman; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-07       Impact factor: 4.733

7.  Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats.

Authors:  Jorge F Giani; Valeria Burghi; Luciana C Veiras; Analía Tomat; Marina C Muñoz; Gabriel Cao; Daniel Turyn; Jorge E Toblli; Fernando P Dominici
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

8.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

Authors:  R A Santos; M J Campagnole-Santos; N C Baracho; M A Fontes; L C Silva; L A Neves; D R Oliveira; S M Caligiorne; A R Rodrigues; C Gropen Júnior
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

9.  Effects of daily sodium intake and ANG II on cortical and medullary renal blood flow in conscious rats.

Authors:  V Gross; T M Kurth; M M Skelton; D L Mattson; A W Cowley
Journal:  Am J Physiol       Date:  1998-05

10.  Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production.

Authors:  Ariel Héctor Polizio; Mariela Mercedes Gironacci; Maria Luján Tomaro; Clara Peña
Journal:  Pharmacol Res       Date:  2007-05-01       Impact factor: 7.658

View more
  4 in total

1.  Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats.

Authors:  Matheus Vinicius Barbosa da Silva; Célio Pereira de Sousa Júnior; Heverton Valentim Colaço da Silva; Vanessa Maria Dos Santos; Francisco Israel Magalhães Feijao; Amanda de Oliveira Bernardino; José Augusto Calafell Roig Tiburcio de Melo
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

2.  Age-related changes in vascular responses to angiotensin-(1-7) in female mice.

Authors:  Fabiana P Costa-Fraga; Gleisy K Goncalves; Fernando P Souza-Neto; Adelina M Reis; Luciano As Capettini; Robson As Santos; Rodrigo A Fraga-Silva; Nikolaos Stergiopulos; Rafaela F da Silva
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jul-Sep       Impact factor: 1.636

Review 3.  ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.

Authors:  Koichi Yamamoto; Hikari Takeshita; Hiromi Rakugi
Journal:  Clin Sci (Lond)       Date:  2020-11-27       Impact factor: 6.124

4.  Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?

Authors:  Andrea Berenyiova; Iveta Bernatova; Anna Zemancikova; Magdalena Drobna; Martina Cebova; Samuel Golas; Peter Balis; Silvia Liskova; Zuzana Valaskova; Katarina Krskova; Stefan Zorad; Ezgi Dayar; Sona Cacanyiova
Journal:  Biomedicines       Date:  2021-12-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.